Walpar Nutritions Ltd
Incorporated in 2009, Walpar Nutritions Ltd manufactures and trades Pharmaceutical, Nutraceutical, Herbal and Ayurvedic commodities[1]
- Market Cap ₹ 62.1 Cr.
- Current Price ₹ 132
- High / Low ₹ 154 / 66.0
- Stock P/E 45.1
- Book Value ₹ 27.7
- Dividend Yield 0.00 %
- ROCE 8.78 %
- ROE 5.26 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 228 to 130 days.
- Company's working capital requirements have reduced from 252 days to 131 days
Cons
- Stock is trading at 4.77 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
|---|---|---|---|---|
| 6.07 | 26.76 | 35.14 | 49.76 | |
| 5.61 | 25.74 | 31.65 | 45.27 | |
| Operating Profit | 0.46 | 1.02 | 3.49 | 4.49 |
| OPM % | 7.58% | 3.81% | 9.93% | 9.02% |
| 0.00 | 0.02 | 0.32 | 0.33 | |
| Interest | 0.18 | 0.48 | 0.79 | 0.69 |
| Depreciation | 0.12 | 0.28 | 1.91 | 1.99 |
| Profit before tax | 0.16 | 0.28 | 1.11 | 2.14 |
| Tax % | 6.25% | -32.14% | 27.03% | |
| 0.15 | 0.36 | 0.81 | 1.79 | |
| EPS in Rs | 0.45 | 0.84 | 1.30 | 2.99 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 70% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 1823% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 89% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
|---|---|---|---|---|
| Equity Capital | 3.34 | 4.54 | 4.54 | 4.70 |
| Reserves | 1.44 | 6.45 | 7.17 | 8.32 |
| 7.49 | 7.25 | 10.30 | 8.66 | |
| 5.73 | 9.85 | 12.29 | 19.93 | |
| Total Liabilities | 18.00 | 28.09 | 34.30 | 41.61 |
| 1.70 | 2.01 | 10.13 | 9.96 | |
| CWIP | 1.22 | 4.48 | 0.02 | 0.03 |
| Investments | 0.00 | 0.49 | 0.02 | 1.88 |
| 15.08 | 21.11 | 24.13 | 29.74 | |
| Total Assets | 18.00 | 28.09 | 34.30 | 41.61 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| -0.31 | -1.08 | 1.10 | |
| -2.02 | -6.14 | -3.44 | |
| 2.95 | 6.71 | 2.42 | |
| Net Cash Flow | 0.62 | -0.51 | 0.07 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Debtor Days | 430.54 | 124.26 | 129.63 |
| Inventory Days | 369.26 | 103.22 | 128.73 |
| Days Payable | 455.40 | 135.07 | 143.88 |
| Cash Conversion Cycle | 344.41 | 92.41 | 114.48 |
| Working Capital Days | 487.07 | 138.17 | 131.40 |
| ROCE % | 4.85% | 8.78% |
Business Overview:[1]
Company manufactures and sells Nutraceutical and Herbal dietary supplement formulations, ingredients and research. It manufactures private label brands for different companies and its own brands, selling through online and direct channels. Company is a specialized Contract manufacturer for different formulation in Nutraceuticals and Herbal products